Raf kinase inhibitor protein (RKIP) in cancer : Metastasis GenesESCARA-WILKE, June; YEUNG, Kam; KELLER, Evan T et al.Cancer metastasis reviews. 2012, Vol 31, Num 3-4, pp 615-620, issn 0167-7659, 6 p.Article

The First Tianjin, China Forum on Tumor MicroenvironmentKELLER, Evan T; LI, Lu-Yuan.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 2, pp 310-313, issn 0008-5472, 4 p.Article

Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar tothat found in bone metastatic prostate cancer cellsZHENG FU; DOZMOROV, Igor M; KELLER, Evan T et al.The Prostate. 2002, Vol 51, Num 1, pp 10-20, issn 0270-4137Article

The role of Wnts in bone metastases : Bone metastasis and cancerHALL, Christopher L; KELLER, Evan T.Cancer metastasis reviews. 2006, Vol 25, Num 4, pp 551-558, issn 0167-7659, 8 p.Article

Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude miceSMITH, Peter C; KELLER, Evan T.The Prostate. 2001, Vol 48, Num 1, pp 47-53, issn 0270-4137Article

The role of Raf kinase inhibitor protein (RKIP) in health and diseaseKELLER, Evan T; ZHENG FU; BRENNAN, Meghan et al.Biochemical pharmacology. 2004, Vol 68, Num 6, pp 1049-1053, issn 0006-2952, 5 p.Article

The impact of chronic estrogen deprivation on immunologic parameters in the ovariectomized rhesus monkey (Macaca mulatta) model of menopauseKELLER, Evan T; JIAN ZHANG; ZHI YAO et al.Journal of reproductive immunology. 2001, Vol 50, Num 1, pp 41-55, issn 0165-0378Article

Reversal of Chemotherapy-Induced Leukopenia Using Granulocyte Macrophage Colony-Stimulating Factor Promotes Bone Metastasis That Can Be Blocked with Osteoclast InhibitorsJINLU DAI; YI LU; CHUNYAN YU et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 12, pp 5014-5023, issn 0008-5472, 10 p.Article

Bone turnover mediates preferential localization of prostate cancer in the skeletonSCHNEIDER, Abraham; KALIKIN, Linda M; MATTOS, Ana C et al.Endocrinology (Philadelphia). 2005, Vol 146, Num 4, pp 1727-1736, issn 0013-7227, 10 p.Article

In vivo real-time imaging of TGF-β-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancerJIAN ZHANG; YI LU; JINLU DAI et al.The Prostate. 2004, Vol 59, Num 4, pp 360-369, issn 0270-4137, 10 p.Article

Pathogenesis and treatment of prostate cancer bone metastases : Targeting the lethal phenotypeLOBERG, Robert D; LOGOTHETIS, Christopher J; KELLER, Evan T et al.Journal of clinical oncology. 2005, Vol 23, Num 32, pp 8232-8241, issn 0732-183X, 10 p.Article

EGFR Ligand Switch in Late Stage Prostate Cancer Contributes to Changes in Cell Signaling and Bone RemodelingDEHAAN, Alyse M; WOLTERS, Natalie M; KELLER, Evan T et al.The Prostate. 2009, Vol 69, Num 5, pp 528-537, issn 0270-4137, 10 p.Article

Prostate cancer cells promote osteoblastic bone metastases through WntsHALL, Christopher L; BAFICO, Anna; JINLU DAI et al.Cancer research (Baltimore). 2005, Vol 65, Num 17, pp 7554-7560, issn 0008-5472, 7 p.Article

Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expressionLIN, Din-Lii; WHITNEY, Mary C; ZHI YAO et al.Clinical cancer research. 2001, Vol 7, Num 6, pp 1773-1781, issn 1078-0432Article

p₂₁ CIP-1/WAF-1 Induction Is Required to Inhibit Prostate Cancer Growth Elicited by Deficient Expression of the Wnt Inhibitor Dickkopf-1HALL, Christopher L; HONGLAI ZHANG; BAILE, Shobun et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 23, pp 9916-9926, issn 0008-5472, 11 p.Article

Soluble receptor activator of nuclear factor κB Fc diminishes prostate cancer progression in boneJIAN ZHANG; JINLU DAI; ZHI YAO et al.Cancer research (Baltimore). 2003, Vol 63, Num 22, pp 7883-7890, issn 0008-5472, 8 p.Article

Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanismJINLU DAI; KELLER, Jill; JIAN ZHANG et al.Cancer research (Baltimore). 2005, Vol 65, Num 18, pp 8274-8285, issn 0008-5472, 12 p.Article

The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-lnduced invasion in prostate cancerMIWA, Sotaro; MIZOKAMI, Atsushi; KELLER, Evan T et al.Cancer research (Baltimore). 2005, Vol 65, Num 19, pp 8818-8825, issn 0008-5472, 8 p.Article

Recent advances in bone-targeted therapies of metastatic prostate cancerXIYUN DENG; GUANGCHUN HE; KELLER, Evan T et al.Cancer treatment reviews. 2014, Vol 40, Num 6, pp 730-738, issn 0305-7372, 9 p.Article

Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiationPETTWAY, Glenda J; MEGANCK, Jeffrey A; KOH, Amy J et al.Bone (New York, NY). 2008, Vol 42, Num 4, pp 806-818, issn 8756-3282, 13 p.Article

Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorptionYI LU; ZHONG CAI; GUOZHI XIAO et al.Cancer research (Baltimore). 2007, Vol 67, Num 8, pp 3646-3653, issn 0008-5472, 8 p.Article

The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance withtwo cell linesTAKEDA, Masashi; MIZOKAMI, Atsushi; MAMIYA, Kiminori et al.The Prostate. 2007, Vol 67, Num 9, pp 955-967, issn 0270-4137, 13 p.Article

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic proteinJINLU DAI; KITAGAWA, Yasuhide; JIAN ZHANG et al.Cancer research (Baltimore). 2004, Vol 64, Num 3, pp 994-999, issn 0008-5472, 6 p.Article

Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitroLIN, Din-Lii; TARNOWSKI, Catherine P; JIAN ZHANG et al.The Prostate. 2001, Vol 47, Num 3, pp 212-221, issn 0270-4137Article

Humoral hypercalcemia of malignancy : Severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 Tax expressionRICHARD, Virgile; LAIRMORE, Michael D; GREEN, Patrick L et al.The American journal of pathology. 2001, Vol 158, Num 6, pp 2219-2228, issn 0002-9440Article